Delivery Order SPE2DB22D3401-SPE2DB25FT4YC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,103.98 to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings on July 24, 2025, with a completion date of July 25, 2025. The contract utilized firm fixed pricing with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a $4,856.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2mg) contraceptive vaginal rings. This is a non-set-aside competitive award with an ultimate completion date of August 25, 2025, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,290.80 to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings. The contract, issued on September 18, 2025, with completion targeted for September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Estring 7.5 mcg/day contraceptive vaginal rings with a ceiling value of $1,374.48. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a non-competitive set-aside transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings with a ceiling value of $3,289.23. This firm fixed-price delivery order is non-competitive and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,681.00 delivery order for Estring 7.5 mcg/day (2mg) rings under a firm fixed-price contract. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a child contract with no set-aside designation, competitively awarded through open competition. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This delivery order awards AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, a contract valued at $4,645.68 for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings. The award is a firm fixed price delivery order with no set-aside designation, issued under a competitive process by the Defense Logistics Agency's Medical Supply Chain. The ultimate completion date is September 19, 2025, with the work performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,579.61 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contraceptive pharmaceutical product will support federal medical supply needs,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, valued at $3,009.21. The delivery order, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisource Bergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS, a type of estrogen vaginal ring medication. The contract has a ceiling value of $1,137.07 and a period of performance through May 28, 2025. This award is not a set-aside contract, indicating open competition. Amerisource Bergen Drug Corp is a...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT4YCDelivery Order
The Defense Logistics Agency awarded a $2,944.85 delivery order to AmerisourceBergen Drug Corp for Estring 7.5 micrograms/day contraceptive rings (2 mg dosage). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 1, 2025. The award was issued on June 30, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports the company's role as a comprehensive pharmaceutical supplier for military healthcare systems and other federal medical programs worldwide, enabling the delivery of a broad spectrum of pharmaceutical products, medical supplies, vaccines, and specialty medications. AmerisourceBergen's consistent receipt of competitively awarded federal contracts demonstrates its established capability to meet Defense Logistics Agency procurement requirements for medical commodities supporting military personnel and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/30/25 |